Recent Releases

Releases

Targene (~39.22%) – successful production of CBG cannabinoid outside of the cannabis plant

August 4, 2022

Response to reports in connection with collaboration with ICL for development of a biological component using RNAi technology 

July 21, 2022

Approval for a pilot towards regulatory clearance in Israel for a biological solution to the palm weevil IIA Grant

June 12, 2022

Results of General Meeting held on May 12, 2022

May 12, 2022

Closing of investment in Targin

April 5, 2022

Development and commercialization agreement for the implementation of a gene identified by the company is canola seeds

February 14, 2022